Hypoactive sexual desire disorder: Difference between revisions
CSV import Tags: Reverted mobile edit mobile web edit |
No edit summary Tag: Manual revert |
||
| Line 42: | Line 42: | ||
{{stub}} | {{stub}} | ||
{{No image}} | {{No image}} | ||
Revision as of 17:16, 22 March 2025
Hypoactive Sexual Desire Disorder (HSDD) is a clinical condition characterized by a persistent or recurrent lack of sexual fantasies or desire for sexual activity. This condition is considered a sexual dysfunction and can cause significant distress or interpersonal difficulties for the individual affected.
Definition and Diagnosis
- HSDD is defined by the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) as a deficiency or absence of sexual fantasies and desire for sexual activity that causes marked distress or interpersonal difficulties. Furthermore, the condition cannot be better explained by a non-sexual mental disorder, a consequence of severe relationship distress or other significant stressors, or attributable to the effects of a substance/medication or another medical condition[1].
- Diagnosis is typically made by a healthcare professional after a thorough medical and psychological examination, along with detailed inquiries about the individual's sexual and psychosocial history.
Causes and Risk Factors
- There are various potential causes and risk factors for HSDD, including both physical and psychological issues:
- Medical conditions such as diabetes, heart disease, or hormonal imbalances can impact sexual desire.
- Certain medications, including some antidepressants and contraceptives, can also decrease sexual desire.
- Psychological issues such as depression, anxiety, or past sexual trauma can contribute to HSDD.
- Relationship issues such as lack of emotional intimacy or unresolved conflict can also be associated with diminished sexual desire[2].
Treatment
- The treatment for HSDD typically involves a combination of medical treatment and psychotherapy:
- Medical treatment may include hormone therapy or FDA-approved medications like flibanserin for premenopausal women.
- Psychotherapy, such as cognitive-behavioral therapy (CBT), can be helpful in addressing underlying psychological issues or improving sexual communication with the partner[3]
Epidemiology
HSDD is a relatively common condition, with studies suggesting that it affects approximately 10% of adult women and is less prevalent among men. The prevalence increases with age and other risk factors[4].
Impact on Quality of Life
HSDD can have a significant impact on an individual's quality of life, affecting self-esteem, body image, and intimate relationships. The distress caused by this condition extends beyond the sexual realm, influencing overall mental health and well-being[5].
See also
- Sexual dysfunction
- Flibanserin
- Cognitive behavioral therapy
- Diagnostic and Statistical Manual of Mental Disorders
References
<references>
- |American Psychiatric Association. (2013). Diagnostic and Statistical Manual of Mental Disorders (5th ed.). Washington, DC: Author.
- |Basson, R. (2010). Women's sexual function and dysfunction: current uncertainties, future directions. International Journal of Impotence Research, 22(5), 266–275.
- |Clayton, A.H., Goldfischer, E.R., Goldstein, I., Derogatis, L., Lewis-D'Agostino, D.J., & Pyke, R. (2013). Validation of the Decreased Sexual Desire Screener (DSDS): a brief diagnostic instrument for generalized acquired female hypoactive sexual desire disorder (HSDD). The Journal of Sexual Medicine, 6(3), 730–738.
- |Shifren, J.L., Monz, B.U., Russo, P.A., Segreti, A., & Johannes, C.B. (2008). Sexual problems and distress in United States women: prevalence and correlates. Obstetrics & Gynecology, 112(5), 970–978.
- |Derogatis, L., Clayton, A., Lewis-D’Agostino, D., Wunderlich, G., & Fu, Y. (2008). Validation of the Female Sexual Distress Scale-Revised for assessing distress in women with hypoactive sexual desire disorder. The Journal of Sexual Medicine, 5(2), 357–364.
</references>


